All In Biotech

Free tool

FAERS Monitor: Oxtellar Xr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202810 or its brand name (Oxtellar Xr, Oxcarbazepine). Reports on generic versions are filed under their own applications.

Reports

16,581

Serious

12,698

77% of reports

Hospitalization

5,075

Death reported

1,331

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,999
  • seizure1,461
  • off label use1,157
  • fatigue860
  • somnolence793
  • hyponatraemia746
  • dizziness727
  • headache715
  • drug interaction701
  • fall628
  • nausea594
  • anxiety514
  • rash504
  • completed suicide503
  • balance disorder499

Reports by year received

View as table
YearReports
200464
200593
2006115
200794
2008208
2009332
2010301
2011378
2012459
2013434
2014438
2015671
2016887
2017894
20181,017
20191,172
20201,556
20211,317
20221,208
20231,308
20241,284
20251,337
20261,011

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,578 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyponatraemiaSignal74617.015.911,110
seizureSignal1,46116.215.520,725
completed suicideSignal5037.77.12,918
balance disorderSignal4997.46.72,731
drug interactionSignal7015.65.22,670
somnolenceSignal7935.04.72,557
fallSignal6282.42.2517
anxietySignal5142.32.1378
drug ineffective1,9991.91.8946
dizziness7271.91.7290
off label use1,1571.71.6329
rash5041.51.376
headache7151.41.3101
fatigue8601.41.3102
nausea5941.00.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.